Apolipoprotein E genotype and gender influence response to tacrine therapy

被引：67

作者：

Farlow, MR

Lahiri, DK

Poirier, J

Davignon, J

Hui, S

机构：

[1] INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46202

[2] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202

[3] MCGILL UNIV,MONTREAL,PQ,CANADA

[4] CLIN RES INST MONTREAL,MONTREAL,PQ H2W 1R7,CANADA

来源：

APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE | 1996年 / 802卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb32603.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：101 / 110

页数：10

共 25 条

[1] [Anonymous], 1976, ECDEU Assessment Manual for Psychopharmacology
[2] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
CORDER, EH
SAUNDERS, AM
STRITTMATTER, WJ
SCHMECHEL, DE
GASKELL, PC
SMALL, GW
ROSES, AD
HAINES, JL
PERICAKVANCE, MA
[J]. SCIENCE, 1993, 261 (5123) : 921 - 923
[3] CORDER EH, 1995, JAMA-J AM MED ASSOC, V273, P373, DOI 10.1001/jama.273.5.373
[4] A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE
FARLOW, M
GRACON, SI
HERSHEY, LA
LEWIS, KW
SADOWSKY, CH
DOLANURENO, J
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18): : 2523 - 2529
[5] APOLIPOPROTEIN-E GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE - IMPLICATIONS FOR THE RISK OF DEMENTIA AMONG RELATIVES
FARRER, LA
CUPPLES, LA
VANDUIJN, CM
KURZ, A
ZIMMER, R
MULLER, U
GREEN, RC
CLARKE, V
SHOFFNER, R
WALLACE, DC
CHUI, H
FLANAGAN, SD
DUARA, R
STGEORGEHYSLOP, P
AUERBACH, SA
VOLICER, L
WELLS, JM
VAN BROECKHOVEN, C
GROWDON, JH
HAINES, JL
[J]. ANNALS OF NEUROLOGY, 1995, 38 (05) : 797 - 808
[6] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
FOLSTEIN, MF
FOLSTEIN, SE
MCHUGH, PR
[J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
[7] FRIZONI GB, 1995, ANN NEUROL, V37, P596
[8] HEFTI F, 1989, PSYCHIATRIC DEV, V4, P297
[9] Progress in molecular genetics of Alzheimer's disease
Hisama, FM
Schellenberg, GD
[J]. NEUROSCIENTIST, 1996, 2 (01) : 3 - 6
[10] A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE
KNAPP, MJ
KNOPMAN, DS
SOLOMON, PR
PENDLEBURY, WW
DAVIS, CS
GRACON, SI
APTER, JT
LAZARUS, CN
BAKER, KE
BARNETT, M
BAUMEL, B
EISNER, LS
CASTELLS, B
BOLOURI, R
BENNETT, D
FORCHETTI, C
LEVIN, A
BLASS, JP
NOLAN, KA
GAINES, ER
RELKIN, N
BORISON, RL
DIAMOND, B
CELESIA, GG
ROSS, AP
DEXTER, J
DOODY, R
LIPSCOMB, L
KREITER, K
DUBOFF, EA
BLOCK, P
MARSHALL, D
WESTERGAARD, N
EARL, NL
WYNE, SV
HINMANSMITH, E
FARLOW, M
HENDRIE, HC
CARESS, JA
FARMER, M
HARPER, JE
FERGUSON, J
FOSTER, NL
BARBAS, NR
BLUEMLEIN, LA
GELB, DJ
BERENT, S
GIORDANI, B
GREENWALD, M
BERGMAN, S
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13): : 985 - 991

← 1 2 3 →